| DB01259 | Lapatinib | approved, investigational | yes | antagonist | Details |
| DB00072 | Trastuzumab | approved, investigational | yes | binderantibody | Details |
| DB04988 | IGN311 | investigational | unknown | | Details |
| DB11973 | Tesevatinib | investigational | unknown | | Details |
| DB05773 | Trastuzumab emtansine | approved, investigational | yes | antibody | Details |
| DB05944 | Varlitinib | investigational | unknown | | Details |
| DB11652 | Tucatinib | approved, investigational | yes | inhibitor | Details |
| DB06021 | AV-412 | investigational | unknown | | Details |
| DB06366 | Pertuzumab | approved | yes | binderantibody | Details |
| DB08916 | Afatinib | approved | yes | inhibitor | Details |
| DB12267 | Brigatinib | approved, investigational | unknown | inhibitor | Details |
| DB12010 | Fostamatinib | approved, investigational | unknown | inhibitor | Details |
| DB15035 | Zanubrutinib | approved, investigational | unknown | inhibitor | Details |
| DB11652 | Tucatinib | approved, investigational | unknown | inhibitor | Details |
| DB14967 | Margetuximab | approved, investigational | yes | antagonist | Details |